Perindopril treatment in the prevention of stroke in experimental animals

Journal of Hypertension, Supplement

Volumn 14, Issue 6, 1996, Pages

  Robert, M K W Lee ^a   Wang, Hong ^a   Smeda, John S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Blood pressure; Cerebral artery; Myogenic response; Perindopril; Stroke

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; HEART RATE; KIDNEY; MALE; MIDDLE CEREBRAL ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; HEART RATE; HYPERTENSION; INDOLES; MALE; MUSCLE, SMOOTH, VASCULAR; PERINDOPRIL; RATS; RATS, INBRED SHR;

EID: 0030477010     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Schachter M: Drug-induced modification of vascular structure: effects of antihypertensive drugs. Am Heart J 1991,122 (suppl):316-323.
2. Schiffrin EL, Deng LY, Larochelle P: Progressive Improvement In the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin 1 -converting enzyme inhibitor: comparison with effects of a β-blocker./m JHypertens 1995,8:229-236.
3. Mulvany MJ: The development and regression of vascular hypertrophy. J Cardiovasc Pharmacol 1992,19 (suppl 2):S22-S27.
4. Korner PI, Bobik A, Jennings GL, Angus JA, Anderson WP: Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Phaimacol 1991,17 (suppl 2):S25-S32.
5. Sihm I, Shroeder AP, Aalkjscr C, e( a/.: Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converb'ng enzyme Inhibitor-based regimen in hypertensive patients. Am J Cardiol 1995,76:38E-40E